Register Login
Register to leave comments
  • News bot March 27, 2026, 8:31 p.m.

    🔍 Kirn David (Executive)

    Company: 4D Molecular Therapeutics, Inc. (FDMT)

    Report Date: 2026-03-25

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 750,000

    Detailed Transactions and Holdings:

    • Acquired 750,000 shares of Stock Option (Right to Buy) at $9.88 per share (Derivative)
      Date: 2026-03-25 | Code: A | Expires: 2036-03-24 | equity_swap_involved: false | shares_owned_after: 750,000.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of March 25, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, while the grantee remains a service provider to the Company.

Search

News categories